Victory Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.43M | Buy |
+17,249
| New | +$1.43M | ﹤0.01% | 1691 |
|
2022
Q3 | – | Sell |
-64,991
| Closed | -$4.83M | – | 2782 |
|
2022
Q2 | $4.83M | Buy |
+64,991
| New | +$4.83M | 0.01% | 1255 |
|
2015
Q4 | – | Sell |
-52,910
| Closed | -$3.29M | – | 1695 |
|
2015
Q3 | $3.29M | Sell |
52,910
-19,759
| -27% | -$1.23M | 0.01% | 583 |
|
2015
Q2 | $6.11M | Sell |
72,669
-21,261
| -23% | -$1.79M | 0.02% | 548 |
|
2015
Q1 | $7.06M | Sell |
93,930
-3,390
| -3% | -$255K | 0.03% | 513 |
|
2014
Q4 | $6.06M | Buy |
+97,320
| New | +$6.06M | 0.02% | 526 |
|
2014
Q2 | – | Sell |
-40,425
| Closed | -$1.92M | – | 926 |
|
2014
Q1 | $1.92M | Sell |
40,425
-2,700
| -6% | -$128K | 0.01% | 428 |
|
2013
Q4 | $1.87M | Buy |
43,125
+975
| +2% | +$42.3K | 0.01% | 442 |
|
2013
Q3 | $1.81M | Buy |
+42,150
| New | +$1.81M | 0.01% | 432 |
|